AN2 Therapeutics Inc Sustainability Reports
A clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform. Its pipeline includes treatments for rare, chronic, and serious infectious diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00QYLYBL3
1 reports from 2022 to 2022
Company Profile
A clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform. Its pipeline includes treatments for rare, chronic, and serious infectious diseases.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
